Moderna (MRNA) Tops Q3 EPS by 195c
Tweet
Share
E-mail
Get Alerts MRNA Hot Sheet
Join SI Premium – FREE
Moderna (NASDAQ: MRNA) reported Q3 EPS of $0.03, $1.95 better than the analyst estimate of ($1.92). Revenue for the quarter came in at $1.86 billion versus the consensus estimate of $1.24 billion.
For earnings history and earnings-related data on Moderna (MRNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robinhood Ventures Fund II opens at $22.50, IPO at $25
- UBS Reiterates Buy Rating on Sysco (SYY) Following Trip to Company Headquarters
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
